Strategic Partnerships NOWDx has a track record of collaborations with major players like Labcorp, and distribution partnerships to bring First To Know tests into professional and healthcare settings. This suggests sales opportunities through channel partnerships, co-marketing arrangements, and bundled offerings with large lab networks and healthcare distributors.

Expansion Readiness With recent leadership change to a new CEO and ongoing clinical and regulatory activity, NOWDx is positioned for growth and market expansion. This creates openings for enterprise accounts and regional distributors seeking innovative OTC/POC diagnostics to broaden their portfolio and address in-home testing demand.

Portfolio Leverage A broad patent portfolio and multiple product lines such as First To Know and ADEXUSDx indicate opportunities to cross-sell and upsell to existing customers, as well as licensing and joint development deals to accelerate market access for additional immunoassays and synergies with complementary tests.

Home and Point-of-Care Focus NOWDx emphasizes in-home and point-of-care testing with rapid results. This aligns with consumer health trends and workplace wellness programs, suggesting sales opportunities with retail pharmacies, telehealth providers, urgent care networks, and employer health initiatives.

Funding Signals Recent Series B funding and ongoing investor activity signal market validation and capital availability for scale. This can be leveraged to pursue strategic sales targets with higher deal values, long-term procurement contracts, and participation in pilot programs or early-access initiatives.